Start-Up
Longevience AB is a Swedish biotechnology company developing AgeViva, an innovative patented dietary supplement derived from yeast cells treated with electromagnetic millimetre wavelengths to promote longevity by targeting multiple hallmarks of ageing. AgeViva is a natural, science-based probiotic, that addresses seven key hallmarks of ageing: anti-inflammation, autophagy promotion, mitochondrial integrity, neurotrophic effects, antioxidant properties, anti-sarcopenia, and enhanced survival. The product has demonstrated effects in both in vitro and in vivo studies with a favourable safety profile, having been consumed by over 1,500 individuals.
Download the white paper on LongeVience - Aging is the major risk factor for chronic diseases